Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
67 | 60 | 59 | 65 | 71 | 11 | 19 | 26 | 45 | 44 | 52 | 59 | 54 | 13 | 14 |
Research, Review articles and Editorials |
14 | 14 | 19 | 41 | 29 | 11 | 15 | 16 | 17 | 34 | 40 | 42 | 38 | 10 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
38 | 46 | 40 | 30 | 42 | 0 | 4 | 10 | 28 | 10 | 12 | 17 | 21 | 3 | 4 |
Conference proceedings |
18 | 8 | 32 | 23 | 0 | 0 | 112 | 104 | 154 | 315 | 180 | 116 | 110 | 122 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
121 | 206 | 193 | 258 | 232 | 212 | 200 | 205 | 224 | 245 | 110 | 61 | 22 | 20 | 0 |
Journal total citations count | 2341 |
Journal impact factor | 2.87 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 4.69 |
Journal h-index | 24 |
Intent to participate in future cervical cancer screenings is lower when satisfaction with the decision to be vaccinated is neutral.
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination
Novel Aspects and Strategies in Vaccination
The dichotomy of pathogens and allergens in vaccination approaches
A Review on Drug Molecules Targeting to Brain
Cloning and expression of the L1 immunogenic protein of human papillomavirus genotype 16 by using Lactobacillus expression system
In a safety net population HPV4 vaccine adherence worsens as BMI increases.
Women have a preference for their male partner to be HPV vaccinated.
Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.
Chapter 14: Prevention: vaccines and immunoglobulins
Immunogenicity and safety of the human papillomavirus vaccine in patients with autoimmune diseases: A systematic review
Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US Midwest.
Current status of human papillomavirus vaccines
Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus.
Cutting Edge Approach on Prodrug: Contrivance for Target Drug Delivery
Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females.
Clinical Illness and Outcomes in Patients with Severe Community-Acquired Pneumonia: A Prospective Study
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies.
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination